While Saxenda is FDA-approved for obesity treatment, Mounjaro is currently FDA-approved as a diabetes drug for type 2 diabetes but is commonly prescribed off-label for weight control
Ozempic NAION Studies Risk Analysis A landmark research establishes the Ozempic-NAION connection, in which among 710 patients with type 2 diabetes, there were 17 cases of NAION in patients prescribed semaglutide, translating to a cumulative rate of 8.9% over three years, compared with six cases in patients prescribed non-GLP-1 diabetes drugs at a rate of 1.8%
You should inject Wegovy on the same day each week, at any time of day, with or without meals
While Mounjaro costs can range from $1,000 to $1,200 monthly, its insurance coverage often aligns with type 2 diabetes needs, necessitating prior authorization processes and specific coverage approvals
Your immune system patrols your bloodstream
A.StaffordB